Which Viral Vector Should You Use for Gene Therapy?
Gene therapy holds immense promise for managing or even curing diseases once considered untreatable. Conditions like certain cancers, β-thalassemia, and retinal dystrophy benefit from this
Gene therapy holds immense promise for managing or even curing diseases once considered untreatable. Conditions like certain cancers, β-thalassemia, and retinal dystrophy benefit from this
Packgene’s comprehensive AAV library design services are tailored to address your specific research needs. Our AAV Library Design Expertise Our Library Design Capabilities Our commitment
So, what exactly are AAVs? Adeno-associated viruses (AAVs) were first identified in 1965 by Bob Atchison and Wallace Rowe, who observed them as replication-defective particles
Adeno-associated viruses (AAVs) have emerged as a powerful tool for gene therapy due to their unique properties: Atlantis Bioscience, in partnership with PackGene, delivers top-tier
Summary Get an insightful overview of the burgeoning field of cell and gene therapies, showcasing their potential to revolutionize medical treatments. Discover the power of
Yamanaka successfully produced embryonic stem cell-like cells in 2006 by introducing Oct3/4, Sox2, c-Myc, and KLF4 into somatic cells. He gave these cells the term
To support preclinical in-vivo research and development, GemPharmatech has developed a comprehensive platform for gene-edited cell line customization, reporter gene cell line
Our dedication to advancing preclinical research goes beyond providing innovative mouse models; we are also committed to supporting our customers by offering preclinical efficacy services.
Contact our Customer Care, Sales & Scientific Assistance
Consult and asked questions about our products & services
Documentation of Technical & Safety Data Sheet, Guides and more..